NCT02300935View on ClinicalTrials.gov

Study of Trametinib and Nab-paclitaxel in Patients With Melanoma

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2015

Primary Completion Date

January 20, 2016

Study Completion Date

January 20, 2016

Conditions
Melanoma
Interventions
DRUG

trametinib

DRUG

nab-paclitaxel

Trial Locations (3)

34232

Florida Cancer Center, Sarasota

37203

Tennessee Oncology PLLC, Nashville

80218

Colorado Blood Cancer Institute, Denver

Sponsors

Collaborators (2)

Celgene
GlaxoSmithKline
All Listed Sponsors
collaborator

Celgene

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER